This book explains the fundamental characteristics and
biofunctionality of Alzheimer’s Disease drug targets and provides
up-to-date information on the full range of their biomedical
applications. An introductory section gives an overview of the
recent developments related to drug targets identified and studied
related to Alzheimer’s Disease and key developments from
preclinical and clinical studies focusing on various molecular
targets related to AD and dementia by subject experts all around
the globe. Here, individual chapters address the progress and
perspectives in human and non-human research, role of various
biomarkers as an overview, advanced gene therapy, and novel
compounds for therapeutic targets for Alzheimer’s disease. The
book will be essential reading for graduate students, scientists,
and engineers in any of the biomedical research fields in which
efforts are being made to utilize novel drug targets and develop
effective strategies for new drug targeting and delivery in
Alzheimer’s disease treatment.
General
Imprint: |
Springer Verlag, Singapore
|
Country of origin: |
Singapore |
Release date: |
September 2023 |
First published: |
2023 |
Editors: |
Dileep Kumar
• Vaishali M. Patil
• Dee Wu
• Nanasaheb Thorat
|
Dimensions: |
235 x 155mm (L x W) |
Pages: |
378 |
Edition: |
1st ed. 2023 |
ISBN-13: |
978-981-9926-56-5 |
Categories: |
Books
|
LSN: |
981-9926-56-4 |
Barcode: |
9789819926565 |
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!